Contraceptive failures in overweight and obese combined hormonal contraceptive users
- PMID: 23635622
- PMCID: PMC4009704
- DOI: 10.1097/AOG.0b013e31828317cc
Contraceptive failures in overweight and obese combined hormonal contraceptive users
Abstract
Objective: To estimate weather contraceptive failure rates among combined oral contraceptive pill (OCP), patch, and vaginal ring users was associated with increasing body mass index (BMI).
Methods: Females enrolled in a large contraceptive study offering the reversible method of their choice at no cost were followed-up for 2-3 years. We compared the failure rates (pregnancy) among users of the OCP, transdermal patch, and contraceptive vaginal ring stratified by BMI.
Results: Among the 7,486 participants available for this analysis, 1,523 chose OCPs, patch, or ring at enrollment. Of the 334 unintended pregnancies, 128 were found to be a result of OCP, patch, or ring failure. Three-year failure rates were not different across BMI categories (BMI less than 25 8.44%, 95% confidence interval [CI] 6.1-11.5; BMI 25-30 11.03%, 95% CI 7.5-16.0; BMI more than 30 8.92%, 95% confidence interval 7.6-11.5). Increasing parity (hazard ratio [HR] 3.06, CI 1.31-7.18) and history of a previous unintended pregnancy (HR 2.82, CI 1.63-4.87), but not BMI, were significant risk factors for unintended pregnancy.
Conclusion: Overweight and obese females do not appear to be at increased risk for contraceptive failure when using the OCP, patch, or vaginal ring.
Figures
Comment in
-
In reply.Obstet Gynecol. 2013 Jul;122(1):156. doi: 10.1097/AOG.0b013e3182995a14. Obstet Gynecol. 2013. PMID: 23787928 No abstract available.
-
Contraceptive failures in overweight and obese combined hormonal contraceptive users.Obstet Gynecol. 2013 Jul;122(1):158-159. doi: 10.1097/AOG.0b013e3182995811. Obstet Gynecol. 2013. PMID: 23787930 No abstract available.
Similar articles
-
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371. Health Technol Assess. 2022. PMID: 36321689 Free PMC article.
-
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Clinical Trial.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.Cochrane Database Syst Rev. 2013 Jul 30;2013(7):CD010041. doi: 10.1002/14651858.CD010041.pub2. Cochrane Database Syst Rev. 2013. PMID: 23897547 Free PMC article. Review.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 27;8:CD007807. doi: 10.1002/14651858.CD007807.pub4 PMID: 28752910 Free PMC article. Updated. Review.
Cited by
-
The contraceptive CHOICE project round up: what we did and what we learned.Clin Obstet Gynecol. 2014 Dec;57(4):635-43. doi: 10.1097/GRF.0000000000000070. Clin Obstet Gynecol. 2014. PMID: 25286295 Free PMC article.
-
Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.J Womens Health (Larchmt). 2017 Aug;26(8):870-877. doi: 10.1089/jwh.2016.5930. Epub 2017 Jan 31. J Womens Health (Larchmt). 2017. PMID: 28140761 Free PMC article.
-
Contraceptive Options Following Gestational Diabetes: Current Perspectives.Open Access J Contracept. 2019 Oct 22;10:41-53. doi: 10.2147/OAJC.S184821. eCollection 2019. Open Access J Contracept. 2019. PMID: 31749639 Free PMC article.
-
Reproductive Planning and the Choice of Long-acting Reversible Contraceptive Primary to Health: A Cross-Sectional Study.Rev Bras Ginecol Obstet. 2023 Aug;45(8):e456-e464. doi: 10.1055/s-0043-1772188. Epub 2023 Sep 8. Rev Bras Ginecol Obstet. 2023. PMID: 37683657 Free PMC article.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article. Review.
References
-
- Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. Jama. 2010;303(3):235–41. Epub 2010/01/15. - PubMed
-
- World Health Organization. Report of a WHO Consultation of Obesity. Geneva -J; Obesity: Preventing and Managing the Global Epidemic. - PubMed
-
- Dinger JC, Cronin M, Mohner S, Schellschmidt I, Minh TD, Westhoff C. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. American journal of obstetrics and gynecology. 2009;201(3):263, e1–9. Epub 2009/06/02. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical